attune™ 4.2.2

Attune™ is the first prescription digital therapeutic tailored to address the symptoms of anxiety and depression associated with cancer.

Implemented through a mobile application, attune™ embodies Cognitive Behavioral Stress Management (CBSM), a behavioral intervention extensively researched and utilized in cancer patients for over two decades. This digital tool offers cognitive behavioral therapy, relaxation therapy, stress management techniques, and coping strategies to complement traditional medical treatments for adult individuals battling cancer.

In June 2020, attune™ was granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration. This recognition underscores the heightened challenges faced by cancer patients today, prompting the FDA to issue immediate enforcement guidance for the program’s swift deployment. Attune™ is exclusively accessible with a valid prescription. To learn more about attune™, kindly visit www.attunerx.com.